Skip to main content
Log in

The consumption of argan oil induces a lipid-lowering effect in dyslipidemic patients

  • Original Article
  • Published:
Mediterranean Journal of Nutrition and Metabolism

Abstract

To manage dyslipidemia using diet recommendations based on argan oil consumption, we were interested in studying, for the first time, the effect of argan oil consumption on plasma lipids in never-treated Moroccan dyslipidemic patients. Twenty-four dyslipidemic patients from the endocrinology department of University Hospital of Rabat (Morocco) were included in this interventional study. The study design consists to two diet periods. In the first diet period of 2 weeks, all patients consumed 20 g/day of butter in breakfast. In the second period of 3 weeks (nutritional intervention), all patients were randomized to two diet groups: one group of 15 patients in which the 20 g/day of butter was substituted by 25 ml/day of argan oil with toasted bread for breakfast. The second group of nine patients for whom, both argan oil and olive oil were removed from their diet while keeping the 20 g/day of butter for breakfast. During this period, all patients were placed under a lifestyle and diet recommended for the dyslipidemic patient as reported by the French Agency for Health Products Safety (AFSSAPS). Serum lipid [total cholesterol (total-chol), triglycerides, low density lipoprotein cholesterol (LDL-chol) and high density lipoprotein cholesterol (HDL-chol)] and anthropometric parameters were measured at the end of both periods. Both groups of patients have showed an improvement of lipid parameters in the end of the interventional period compared to the end of stabilization period by reducing total-chol and LDL-chol; and triglycerides and increasing HDL-chol. However, the change in atherogenic lipids was significantly different (P < 0.04) in the consumers group of argan oil compared to the control group; 30 versus 14% for total-chol, 46 versus 24.5% for triglycerides, 24 versus 15% for LDL-chol, respectively. While the increase in HDL-chol in consumers group of argan oil was different but not significantly compared to the control group; 17 versus 14% (P = 0.1). We have demonstrated for the first time that consumption of argan oil improves the lipid status in never-treated patients with dyslipidemia and can therefore be recommended in nutritional prevention in the management of dyslipidemia.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Omelchenko A (2009) A lead as an environmental cardiovascular risk factor. Period Biol 1:91–98

    Google Scholar 

  2. El Ayachi M, Mziwira M, Vincent S et al (2005) Lipoprotein profile and prevalence of cardiovascular risk factors in urban Moroccan women. Eur J Clin Nutr 12:1379–1386

    Article  Google Scholar 

  3. Cicero AFG, Derosa G, Bove M, Imola F, Borghi C, Gaddi AV (2010) Psyllium improves dyslipidaemia, hyperglycaemia and hypertension, while guar gum reduces body weight more rapidly in patients affected by metabolic syndrome following an AHA Step 2 diet. Mediterr J Nutr Metab 3:47–54

    Article  Google Scholar 

  4. Kromhout D, Menotti A, Kesteloot H, Sans S (2002) Prevention of coronary heart disease by diet and lifestyle. Circulation 105:893–898

    Article  Google Scholar 

  5. Herold PM, Kinsella JE (1986) Fish oil consumption and decreased risk of cardiovascular diseases: a comparison of findings from animal and human feeding trials. Am J Clin Nutr 43:566–598

    CAS  Google Scholar 

  6. Karatayev O, Gaysinskaya V, Chang GQ, Leibowitz SF (2009) Circulating triglycerids after a high-fat meal: predictor of increased caloric intake, orexigenic peptide expression, and dietary obesity. Brain Res 1298:111–122

    Article  CAS  Google Scholar 

  7. Kagan A, Harris BR, Winkelstein W Jr et al (1974) Epidemiologic studies of coronary heart disease and stroke in Japanese men living in Japan, Hawaii and California: demographic, physical, dietary and biochemical characteristics. J Chronic Dis 27:345–364

    Article  CAS  Google Scholar 

  8. Posner BM, Cobb JL, Belanger AJ, Cupples LA, D’Agostino RB, Stokes J 3rd (1991) Dietary lipid predictors of coronary heart disease in Men. Arch Intern Med 151:1181–1187

    Article  CAS  Google Scholar 

  9. Shekel RB, MacMillan SA, Oglesby P et al (1981) Diet, serum cholesterol. The western electric study. N Engl J Med 304:65–70

    Article  Google Scholar 

  10. Khallouki F, Younos C, Soulimani R et al (2003) Consumption of argan oil (Morocco) with its unique profile of fatty acids tocopherols, squalene, sterols, and phenolic compounds should confer valuable cancer chemo-preventive effects. Eur J Cancer Prev 12:67–75

    Article  CAS  Google Scholar 

  11. Berrada Y, Settaf A, Baddouri K, Cherrah A, Hassar M (2000) Experimental evidence of an antihypertensive and hypocholesterolemic effect of oil of organ, Argania sideroxylon. Therapie 55:375–378

    CAS  Google Scholar 

  12. Berrougui H, Ettaib A, Herrera Gonzalez MD, de Alvarez sotomayor M, Bennani-Kabchi N, Hmamouchi M (2003) Hypolipidemic and hypocholesterolemic effect of Argan oil in Meriones shawi rats. J Ethnopharmacol 89:15–18

    Article  CAS  Google Scholar 

  13. Berrougui H, Alvarez de sotomayor M et al (2004) Argan (argania spinosa) oil lowers blood pressure and improves endothelial dysfunction in spontaneously hypertensive rats. Br J Nutr 92:921–929

    Article  CAS  Google Scholar 

  14. Drissi A, Girona J, Cherki M et al (2004) Evidence of hypolipemiant and antioxidant properties of argan oil derived from the argan tree (argania spinosa). Clin Nutr 23:1159–1166

    Article  CAS  Google Scholar 

  15. Derouiche A, Cherki M, Drissi A et al (2005) Nutrition intervention study with argan oil in man: effects on lipids and apolipoproteines. Ann Nutr Metab 49:196–201

    Article  CAS  Google Scholar 

  16. Richmond N (1973) Preparation and properties of a cholesterol oxidase from Nocardia sp. and its application to the enzymatic assay of total cholesterol in serum. J Clin Chem 19:1350–1356

    CAS  Google Scholar 

  17. Friedewald WT, Levy RI, Fredrickson DS (1972) Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18:499–502

    CAS  Google Scholar 

  18. Trinder P (1969) Enzymatic method of triglycerides. Ann Clin Biochem 6:24–27

    CAS  Google Scholar 

  19. Samane S, Christon R, Dombrowski L et al (2009) Fish oil and argan oil intake differently modulate insulin resistance and glucose intolerance in a rat model of dietary induced obesity. Metabolism Clin Exp 58:909–919

    Article  CAS  Google Scholar 

  20. Miller N (1978) The evidence for the anti-atherogenecity of HDL in man. Symposium on HDL structure function analysis, clinical, epidemiological aspect of HDL. Lipids 13:914–918

    Article  CAS  Google Scholar 

  21. Sola R, Baudet M, Motta C (1993) Dietary monounsaturated fatty acids enhance cholesterol efflux from fibroblasts. Relation to fluidity, phospholipid fatty acid composition, overall composition and size of HDL3. Arterioscler Thromb 13:958–966

    Article  CAS  Google Scholar 

  22. Sola R, Baudet MF, Motta C, Maille M, Boisnier C, Jacotot B (1990) Effects of dietary fats on the fluidity of human high-density lipoprotein: influence of the overall composition and phospholipid fatty acids. Biochim Biophys Acta 1043:43–51

    Article  CAS  Google Scholar 

  23. Frank B, Hu M, Meir J et al (1997) Dietary fat intake and the risk of coronary heart disease in women. N Engl J Med 337:1491–1499

    Article  Google Scholar 

  24. Trautwein EA, Rieckhoff D, Kunath-Rau A, Erbersdobler HF (1999) Replacing saturated fat with PUFA-rich (sunflower oil) or MUFA-rich (rapeseed, olive and high-oleic sunflower oil) fats resulted in comparable hypocholesterolemic effects in cholesterol-fed hamsters. Ann Nutr Metab 43:159–172

    Article  CAS  Google Scholar 

  25. Keys A, Minotti A, Karvonen MJ (1996) The diet and 15-year death rate in the Seven Countries study. Am J Epidemiol 124:903–915

    Google Scholar 

  26. Lin He MS, Maria LF (1998) Saturated fat and simple carbohydrates elevate plasma LDL cholesterol concentrations by specific alterations on hepatic cholesterol metabolism. Nutrition Research 18:1003–1015

    Article  Google Scholar 

  27. Richard JL, Marin C, Maille M, Mendy F, Delolanque B, Jacotot B (1990) Effect of dietary intake of gamma linolenique acid on blood lipids and phospholipid fatty acids in healthy human subject. J Clin Biochem Nutr 8:75–84

    Article  CAS  Google Scholar 

  28. Atikah FD, Siddik N, Sembiring TB, Ariani A (2009) The effect of dietary intervention and physical activities on the lipid profile of obese children. Pediatr Indones 2:108–111

    Google Scholar 

  29. Cecilia B, Rosalba S, Tiziana A (1998) Free fatty acids modulate LDL receptor activity in BHK-21 cells. Atherosclerosis 137:329–340

    Article  Google Scholar 

  30. Adlouni A, Cherki M, Khalil A, El Messal M (2009) Argan oil may reduce cardiovascular risk associated with obesity. Atherosclerosis 10:385

    Article  Google Scholar 

  31. Nagyova A, Haban P, Klvanova J, Kadrabova J (2003) Effects of dietary extra virgin olive oil on serum lipid resistance to oxidation and fatty acid composition in elderly lipidemic patients. Bratisl Lek Listy 104:218–221

    CAS  Google Scholar 

  32. Heinemann T, Axtmann G, Von Bergmann K (1993) Comparison of intestinal absorption of cholesterol with different plant sterol in man. Eur J Clin Invest 23:827–831

    Article  CAS  Google Scholar 

  33. Khandelwal S, Demonty I, Jeemon P (2009) Independent and interactive effects of plant sterols and fish oil n-3 long-chain polyunsaturated fatty acids on the plasma lipid profile of mildly hyperlipidaemic Indian adults. Br J Nutr 102:722–732

    Article  CAS  Google Scholar 

  34. Demonty I, Ras RT, van der Knaap HC, Duchateau GS, Meijer L, Zock PL, Geleijnse JM, Trautwein EA (2009) Continuous dose-response relationship of the LDL-cholesterol–lowering effect of phytosterol intake. J Nutr 2:271–284

    Google Scholar 

  35. Marangoni F, Poli A (2010) Phytosterols and cardiovascular health. Pharmacol Res 61:193–199

    Article  CAS  Google Scholar 

  36. Varady KA, St Pierre AC, Lamarche B, Jones PJH (2005) Effect of plant sterols and endurance training on LDL particle size and distribution in previously sedentary hypercholesterolemic adults. Eur J Clin Nutr 59:518–525

    Article  CAS  Google Scholar 

  37. Malinowski JM, Gehret MM (2010) Phytosterols for dyslipidemia. Am J Health Syst Pharm 14:1165–1173

    Article  Google Scholar 

Download references

Acknowledgments

The authors gratefully would like to thank Zakaria Ouissafane, the Argan oil Company Director for his contribution of argan oil needed in the study. Also, our thanks are given to Agrotech Association SMD for their financial support and to Dr A. Belhouari for his statistical analysis.

Conflict of interest

None.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ahmed Adlouni.

About this article

Cite this article

Ould Mohamedou, M.M., Tacha, A., El Messal, M. et al. The consumption of argan oil induces a lipid-lowering effect in dyslipidemic patients. Mediterr J Nutr Metab 5, 143–147 (2012). https://doi.org/10.1007/s12349-011-0080-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12349-011-0080-9

Keywords

Navigation